Keeping up with the latest developments? Here are ten recent articles every clinician working in psychiatric care should read this week.

1. Is Bad Skin Driving Some Patients to Suicide?
The incidence of psychiatric disorders among dermatology patients is high, with estimates ranging between 30 to 40 percent.

2. 2013 CPT Billing Code Changes for Psychiatry
Major changes have been enacted to the codes in the Psychiatry section of the American Medical Association’s manual on Current Procedural Terminology, 4th Edition.

3. The ABCs of Telepsychiatry
Telepsychiatry is a form of videoconferencing that can provide psychiatric services to patients living in remote locations or otherwise underserved areas.

4. 8 Strategies for Your Patients to Better Manage Stress
Despite the commonness and destructive sequelae of stress, Americans are not receiving adequate stress management guidance from their health care providers, according to a recent study.

5. Can Pediatric Neuroenhancement Be Justified?
Neuroenhancement is “the use of prescription medication by healthy persons for the purpose of augmenting normal cognitive or affective function”—a practice that is increasing in adult, pediatric, and adolescent populations.

6. Prevention and Early Intervention in Borderline Personality Disorder
It is commonly believed that BPD cannot be diagnosed in adolescents. However, current evidence suggests that there is considerable “flexibility and malleability” of BPD in youth, making adolescence a “key developmental period” for intervention.

7. Recognizing and Treating Prodrome in Bipolar Disorder
Bipolar disorder is a chronic, episodic, progressive illness. Intervening prior to an episode (either the first episode, or an episodic relapse) can therefore mitigate disease progression.

8. Will Memantine Work for Non-Dementia Psychiatric Disorders?
A recently published review by Sani and colleagues looks at current preclinical and clinical evidence for the use of memantine in psychiatric disorders other than the dementias.

9. Managing Metabolic Syndrome in Schizophrenia
Patients with schizophrenia carry a heightened risk for developing metabolic syndrome. The prevalence of dyslipidemia, hypertension, obesity, and type 2 diabetes is approximately 1.5 to 2 times higher in individuals with schizophrenia and related disorders than in the general population.

10. Depression in Neurological Disease
Depression is frequently underdiagnosed and undertreated in patient with MS, PD, AD, and epilepsy. Reasons for this underdiagnosis might include the difficulty of distinguishing between depressive and neurological symptoms, and the communication limitations experienced by neurologically impaired patients.